Eyebright Medical Technology Beijing Co Ltd (688050)

Currency in CNY
77.29
+0.11(+0.14%)
Closed·

688050 Financial Summary

Key Ratios

P/E Ratio35.77
Price/Book5.54
Debt / Equity23.89%
Return on Equity14.83%
Dividend Yield0.45%
EBITDA565.64M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of CNY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.00%
Dividend Yield
0.45%
Industry Median 1.84%
Annualised payout
0.35
Paid annually
5-Years Growth
-
Growth Streak

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 114.67
(+48.36% Upside)

Earnings

Latest Release
Apr 22, 2025
EPS / Forecast
0.49 / 0.93
Revenue / Forecast
357.18M / 525.03M
EPS Revisions
Last 90 days

FAQ

What were Eyebright Medical Technology Beijing's earnings for the latest quarter?

The Eyebright Medical Technology Beijing EPS (TTM) is 2.00. Eyebright Medical Technology Beijing reported sales of 357.18, net income of 92.56, and EPS of 0.49 for the latest quarter.

What was Eyebright Medical Technology Beijing's net income for the latest quarter?

Eyebright Medical Technology Beijing's net income for the latest quarter was 92.56.

How did Eyebright Medical Technology Beijing's performance compare year-over-year in the latest quarter?

The company's revenue moved from 334.76 in the previous quarter to 357.18 in the latest quarter, and net income moved from 70.81 to 92.56 compared to the previous quarter.

What is Eyebright Medical Technology Beijing's net profit margin on a TTM basis?

Eyebright Medical Technology Beijing's trailing twelve months (TTM) net profit margin is 27.55%.

How does Eyebright Medical Technology Beijing's debt to equity ratio compare to industry standards?

Eyebright Medical Technology Beijing's total debt-to-equity ratio is 23.89%.

What is Eyebright Medical Technology Beijing's return on investment on a TTM basis?

Eyebright Medical Technology Beijing's trailing twelve months (TTM) return on investment (ROI) is 14.83%.

Did Eyebright Medical Technology Beijing gain or lose cash last quarter?

In the latest quarter, Eyebright Medical Technology Beijing's net change in cash was -21.57 million.

What were Eyebright Medical Technology Beijing's total assets and liabilities in the latest quarter?

As of the latest quarter, Eyebright Medical Technology Beijing reported total assets of 3,536.08 million and total liabilities of 276.61 million.

How has Eyebright Medical Technology Beijing's total revenue grown this year?

Eyebright Medical Technology Beijing's total revenue was 334.76 in the previous quarter and 357.18 in the latest quarter.

What is Eyebright Medical Technology Beijing's gross margin on a TTM basis?

Eyebright Medical Technology Beijing's trailing twelve months (TTM) gross margin is 64.43%.

What was Eyebright Medical Technology Beijing's revenue per share for the latest quarter?

Eyebright Medical Technology Beijing's revenue per share for the latest quarter was 6.38.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.